Review

lewis lung carcinoma (ATCC)

ATCC is a verified supplier

ATCC manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

ATCC lewis lung carcinoma
Lewis Lung Carcinoma, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1261 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lewis+lung+carcinoma/LL%2F2/pmc13004575-62-7-11
Average 99 stars, based on 1261 article reviews

lewis lung carcinoma - by Bioz Stars, 2026-09

99/100 stars

Images

Cell Culture:

Article Title: Modified tumor uptake and biodistribution of nanoparticles coated with small extracellular vesicle membranes derived from distinct tumor cell lines.
Article Snippet: .. Mycoplasm-free murine breast cancer (4T1, ATCC CRL-2539), Lewis lung carcinoma (LLC, ATCC CRL-1642), and squamous cell carcinoma (SCCVII, Dept. of Radiology, Tokyo university) were cultured in DMEM supplemented with 10% FBS and 1% P/S. ..

Article Title: Glucagon-like peptide-1 receptor agonism improves lung cancer outcomes and tumor growth control.
Article Snippet: .. The murine lung cancer cell lines KPN 1.1 (48) (provided by Dr. N. Joshi, Yale School of Medicine, New Haven, CT) and Lewis Lung Carcinoma (LLC; ATCC # CRL-1642-LUC2) were cultured in vitro and harvested in the logarithmic phase by trypsinization, followed by centrifugation. ..

Article Title: Modified tumor uptake and biodistribution of nanoparticles coated with small extracellular vesicle membranes derived from distinct tumor cell lines
Article Snippet: .. Mycoplasm-free murine breast cancer (4T1, ATCC CRL-2539), Lewis lung carcinoma (LLC, ATCC CRL-1642), and squamous cell carcinoma (SCCVII, Dept. of Radiology, Tokyo University) were cultured in DMEM supplemented with 10% FBS and 1% P/S. ..

In Vitro:

Centrifugation:

other:

Article Title: Exploring the role of sialidases in Galectin-1-associated resistance to cancer therapies.
Article Snippet: The diverse repertoire of cell surface glycans, generated by the coordinated activity of glycosyltransferases and glycosidases, encodes critical biological information that is interpreted by glycan-binding proteins including galectins.. Galectin-1 (GAL1), a member of this family, plays key roles across multiple hallmarks of cancer, including angiogenesis and immune evasion, driving resistance to anti-angiogenic and immunotherapeutic strategies through glycosylation-dependent mechanisms.. Here, we first review the contribution of GAL1–glycan interactions to therapeutic resistance in cancer, with a particular focus on anti-angiogenic therapies and immunotherapy, and discuss the central role of glycosyltransferases in shaping these responses.